Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: An open-label trial

Neurological Sciences

Volumn 32, Issue 6, 2011, Pages 1063-1067

  López Gómez, Mario ^a   Corona, Teresa ^a   Diaz Ruiz, Araceli ^a   Ríos, Camilo ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Dapsone; Drug resistant epilepsy; Epilepsy treatment; Partial onset epilepsy

Indexed keywords

CARBAMAZEPINE; DAPSONE; LAMOTRIGINE; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; METHEMOGLOBINEMIA; NONHUMAN; OPEN STUDY; PALLOR; PARTIAL ONSET SEIZURE; PARTIAL SECONDARY GENERALIZED SEIZURE; PHASE 1 CLINICAL TRIAL; RAT; RISK REDUCTION; SEIZURE; SOMNOLENCE; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTICONVULSANTS; DAPSONE; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEPROSTATIC AGENTS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84856213805     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0612-6     Document Type: Article

References (17)

1. Mandell GL, Petri WA Jr (1996) Drugs used in chemotherapy of tuberculosis, diseases caused by Mycobacterium avium and leprosy. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. McGraw Hill, New York, pp 1155-1174
2. Hamada K, Hiyoshi T, Kobayashi S et al (1991) Anticonvulsive effect of dapsone on amygdala-kindled seizures in rats and cats. Epilepsy Res 10:93-102
3. Ishida S, Hamada K, Yagi K et al (1992) Comparing the anticonvulsive effects of dapsone on amygdala-kindled seizures and hippocampal-kindled seizures in rats. Acta Neurol Scand 85:132-135
4. Rios C, Altagracia M, Kravzov J et al (1993) EEG evaluation of the anticonvulsive effect of dapsone in the kainic acid model of epilepsy. Proc West Pharmacol Soc 36:259-261 (Pubitemid 23202955)
5. Altagracia M, Monroy-Noyola A, Osorio-Rico L et al (1994) Dapsone attenuates kainic acid-induced seizures in rats. Neurosci Lett 176:52-54 (Pubitemid 24231468)
6. Dietrich M, Gaus W, Kern P et al (1994) An international randomized study with long-term follow-up of single versus combination chemotherapy of multibacillary leprosy. Antimicrob Agents Chemother 38:2249-2257 (Pubitemid 24304212)
7. Garcia-Arenas G, Flores-Murrieta FJ, Rios C (1997) Anticonvulsive effects of dapsone: Interaction with phenytoin in the kainic acid modelo f seizures. Proc West Pharmacol Soc 40:95-96
8. Zuidema J, Hilbers-Modderman ES, Merkus FW (1986) Clinical pharmacokinetics of dapsone. Clin Pharmacokinet 11:299-315 (Pubitemid 16044234)
9. Williams S, MacDonald P, Hoyer JD et al (2005) Methemoglobinemia in children with acute lymphoblastic leukemia receiving dapsone for Pneumocystis carinii pneumonia prophylaxis: A correlation with cytochrome b5 reductase and enzyme levels. Pediatr Blood Cancer 44:55-62 (Pubitemid 39602568)
10. The US Gabapentin-Study Group No. 5 (1993) Gabapentin as add-on therapy for refractory partial epilepsy: A double-blind placebo controlled parallel-group study. Neurology 43(11):2292-2298
11. Anhut H, Ashman P, Feuerstein TJ et al (1994) Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: A double-blind placebo controlled study. The International Gabapentin Study Group. Epilepsia 35:795-801 (Pubitemid 24278033)
12. Messenheimer J, Ramsay RE, Willmore LJ (1994) Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 35:113-121 (Pubitemid 24074474)
13. Faught E, Wilder BJ, Ramsay RE et al (1996) Topiramate placebo- controlled dose-ranging trial in refractory partial epilepsy using 200-, 400- and 600-mg daily dosages: Topiramate YD Study Group. Neurology 46:1684-1690 (Pubitemid 26185793)
14. Shorvon SD, Löwenthal A, Janz D et al (2000) Multicenter double-blind randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsy 41:1179-1186
15. Zhou SF, Zhou ZW, Yang LP et al (2009) Substrates, inducers, inhibitors and structure-activity relationships of human cytochrome P450 2C9 and implications in drug development. Curr Med Chem 16:3480-3675
16. Zhu YI, Stiller MJ (2001) Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol 45:420-434 (Pubitemid 32800500)
17. Leppik IE (2004) Zonisamide: Chemistry, mechanism of action, and pharmacokinetics. Seizure 13:S5-S9 (Pubitemid 39420012)